Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Song C. Ong"'
Autor:
Song C Ong, Vineeta Kumar
Publikováno v:
Brazilian Journal of Nephrology (2022)
Externí odkaz:
https://doaj.org/article/a8452488413b40e092d49159c09edfdb
Autor:
John T. Killian, Julie A. Houp, Greer A. Burkholder, Salomon A. Roman Soto, A. Cozette Killian, Song C. Ong, Nathaniel B. Erdmann, Paul A. Goepfert, Vera Hauptfeld-Dolejsek, Sixto M. Leal, Esther Zumaquero, Anoma Nellore, Gaurav Agarwal, Clifton E. Kew, Babak J. Orandi, Jayme E. Locke, Paige M. Porrett, Emily B. Levitan, Vineeta Kumar, Frances E. Lund
Publikováno v:
Transplant International. 35
Alloimmune responses in kidney transplant (KT) patients previously hospitalized with COVID-19 are understudied. We analyzed a cohort of 112 kidney transplant recipients who were hospitalized following a positive SARS-CoV-2 test result during the firs
Autor:
Song C Ong, Vineeta Kumar
Publikováno v:
Brazilian Journal of Nephrology, Issue: ahead, Published: 21 FEB 2022
Brazilian Journal of Nephrology, Volume: 44, Issue: 3, Pages: 303-304, Published: 21 FEB 2022
Brazilian Journal of Nephrology, Volume: 44, Issue: 3, Pages: 303-304, Published: 21 FEB 2022
Autor:
Connie M. Rhee, Song C Ong
Publikováno v:
Current opinion in nephrology and hypertension. 30(1)
Purpose of review Posttransplant diabetes mellitus (PTDM) is a prevalent complication in kidney transplant recipients, and has been associated with worse short-term and long-term outcomes. Recent findings While hyperglycemia is frequently seen in the
Autor:
Song C, Ong, Robert S, Gaston
Publikováno v:
Transplantation. 105(3)
Tacrolimus was discovered in 1984 and entered clinical use shortly thereafter, contributing to successful solid organ transplantation across the globe. In this review, we cover development of tacrolimus, its evolving clinical utility, and issues affe
Publikováno v:
Clinical transplants. 32
Recent literature suggests that a positive crossmatch adversely impacts outcomes in simultaneous liver-kidney transplant (SLKT). The aim of this study was to evaluate outcomes of SLKT with a positive flow crossmatch (+FCXM) at our center. We retrospe